ROYCE & ASSOCIATES LP - PDL BIOPHARMA INC ownership

Back to all holdings Add to watchlist

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 186 filers reported holding PDL BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q2 2018$19,000
+35.7%
8,036
+73.9%
0.00%–
Q1 2018$14,0000.0%4,622
-7.8%
0.00%–
Q4 2017$14,000
-6.7%
5,015
+16.6%
0.00%–
Q3 2017$15,000–4,302–0.00%–
 Download
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2017
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders